Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Laura S. Angelo
Targeting Hypoxia-Inducible Factor-1α (HIF-1α) in Combination With Antiangiogenic Therapy: A Phase I Trial of Bortezomib Plus Bevacizumab
Oncotarget
Oncology
R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis
PLoS ONE
Multidisciplinary
Related publications
Tissue Expression of Hypoxia-Inducible Factor 1 Alpha (HIF-1A) in Wilms Tumor
Journal of Dr Behcet Uz Children s Hospital
Increased Antitumor Activity of Bevacizumab in Combination With Hypoxia Inducible Factor-1 Inhibition
Molecular Cancer Therapeutics
Cancer Research
Oncology
Hypoxia-Inducible Factor-1α Induces Multidrug Resistance Protein in Colon Cancer
OncoTargets and Therapy
Oncology
Pharmacology
A Dynamic Model of the Hypoxia-Inducible Factor 1 (HIF-1 ) Network
Journal of Cell Science
Cell Biology
Natural Product-Based Inhibitors of Hypoxia-Inducible Factor-1 (HIF-1)
Current Drug Targets
Molecular Medicine
Drug Discovery
Clinical Biochemistry
Pharmacology
Correction: The Role of Hypoxia Inducible Factor-1 Alpha in Bypassing Oncogene-Induced Senescence
PLoS ONE
Multidisciplinary
Expression Significance and Potential Mechanism of Hypoxia‐inducible Factor 1 Alpha in Patients With Myelodysplastic Syndromes
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Targeting the Hypoxia-Inducible Factor (HIF) Pathway in Cancer
Expert Reviews in Molecular Medicine
Molecular Medicine
Molecular Biology
P300 Relieves P53-Evoked Transcriptional Repression of Hypoxia-Inducible Factor-1 (HIF-1)
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
